Author

Daniel Skhisov

University of Colorado AnschutzORCID 0009-0009-7014-0803Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Abby AstiD· 1 shared Andre NavarroiD· 1 shared Anh T. Le· 1 shared Jasalyn T. Avila· 1 shared Lynn E. HeasleyiD· 1 shared Raphael A. NemenoffiD· 1 shared Samantha HainesiD· 1 shared Sophia JaramilloiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abby AstORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma

Trista K. Hinz, Anh T. Le, Tristan Doan, Abby Ast, Sophia Jaramillo, Jasalyn T. Avila, Daniel Skhisov, Samantha Haines, Andre Navarro, Tejas Patil, Raphael A. Nemenoff, Lynn E. Heasley

This study models acquired resistance to RET inhibitors in murine lung cancer and identifies combination therapies that improve treatment outcomes.

Cancer Letters · Mar 31, 2026Peer-reviewedCancer Biology